India's H5N1 Chicken Vaccine Set for Launch on November 20, 2026

India prepares to introduce its first homegrown H5N1 vaccine for poultry, targeting a strain responsible for numerous outbreaks.

A
Aapla Nagpur Desk
18 Nov 2026, 10:28 PM IST · 2 min read
Source: Today
India's H5N1 Chicken Vaccine Set for Launch on November 20, 2026
KEY TAKEAWAYS
1

The vaccine addresses H5N1 Clade 2.3.2.1a, a major threat to poultry.

2

Over 500 H5N1 outbreaks have been recorded in India since 2006.

3

Economic impacts of bird flu could reduce India's GDP growth by 1.5%.

India is poised to launch its inaugural domestically developed vaccine for H5N1 in chickens on November 20, 2026. This vaccine specifically targets the H5N1 Clade 2.3.2.1a strain, which has been identified as a significant contributor to bird flu outbreaks affecting poultry across the nation. The Indian Council of Agricultural Research's National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal has spearheaded the development of this vaccine, marking a critical advancement in the country's efforts to combat avian influenza.

Since the first detection of avian influenza in India in 2006, the country has faced over 500 outbreaks involving H5N1 and H5N8 subtypes. The highly pathogenic nature of avian influenza poses a severe risk to poultry, often resulting in high mortality rates among infected birds. Control measures, such as mass culling and movement restrictions, have been implemented to mitigate the spread, significantly disrupting poultry commerce both domestically and internationally.

The economic ramifications of the 2006 outbreak were substantial, with losses estimated between 22 billion and 30 billion rupees. The impact of poultry disease outbreaks extends beyond farmers to include businesses involved in feed supply, processing, and distribution of poultry products. The Ministry of Agriculture and Farmers Welfare has indicated that a major outbreak could potentially decrease India's GDP growth by as much as 1.5%, with over 20% of the national poultry population at risk if effective control measures are not established.

Infections of the H5N1 Clade 2.3.2.1a strain have been reported in various animal species, including mammals, and there have been three documented human infections associated with this strain. The government's announcement emphasizes the importance of biosecurity measures on farms, particularly those that house both dairy cattle and poultry, to prevent cross-contamination and ensure hygiene.

Looking ahead, the introduction of this vaccine is expected to bolster India's defenses against avian influenza, enhancing biosecurity and potentially stabilizing the poultry industry. As the launch date approaches, stakeholders in the agricultural sector are keenly observing the developments, anticipating the vaccine's role in mitigating future outbreaks and their associated economic impacts.

💬What did you think of this story?What did you think?

Read Next

India Launches H5N1 Chicken Vaccine on Nov 20, 2026